Regulatory watch: The target product profile as a tool for regulatory communication: advantageous but underused.
作者信息
Tyndall Adria, Du Wenny, Breder Christopher D
机构信息
Catalent Pharma Solutions, 2210 Lakeshore Drive, Woodstock, Illinois 60098, USA.
JHUAAP and contributed equally to this project.
出版信息
Nat Rev Drug Discov. 2017 Mar;16(3):156. doi: 10.1038/nrd.2016.264. Epub 2017 Feb 17.
Abstract
摘要
相似文献
1
Regulatory watch: The target product profile as a tool for regulatory communication: advantageous but underused.监管观察：目标产品概况作为监管沟通工具：具有优势但未得到充分利用。
Nat Rev Drug Discov. 2017 Mar;16(3):156. doi: 10.1038/nrd.2016.264. Epub 2017 Feb 17.
2
A cheat sheet to navigate the complex maze of exclusivities in the United States.一份用于在美国错综复杂的专有权益迷宫中导航的备忘单。
Pharm Pat Anal. 2014 Jul;3(4):339-43. doi: 10.4155/ppa.14.30.
3
FDA to steer nanotech.美国食品药品监督管理局将引领纳米技术发展。
Nat Biotechnol. 2008 Oct;26(10):1060. doi: 10.1038/nbt1008-1060a.
4
Bush tails follow-ons.布什尾巴后续行动。
不过你提供的“Bush tails”这个表述不太明确其确切含义，可能有更准确的翻译，以上是基于字面意思的翻译。
Nat Biotechnol. 2008 Apr;26(4):366. doi: 10.1038/nbt0408-366a.
5
The FDA: is it protecting the public with one hand tied behind its back?美国食品药品监督管理局：它是否在一只手被束缚的情况下保护公众？
Law Med Health Care. 1992 Fall;20(3):253-7. doi: 10.1111/j.1748-720x.1992.tb01199.x.
6
Regulatory experts debate FDA's authority.监管专家就美国食品药品监督管理局的权限展开辩论。
Am J Health Syst Pharm. 2007 May 1;64(9):910, 912. doi: 10.2146/news070040.
7
Paying for drug approvals--who's using whom?为药物审批付费——谁在利用谁？
N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.
8
Regulatory watch: impact of PDUFA on regulatory decision-making.监管观察：《处方药用户付费法案》对监管决策的影响
Nat Rev Drug Discov. 2010 Aug;9(8):585. doi: 10.1038/nrd3247.
9
Drug safety reform at the FDA--pendulum swing or systematic improvement?美国食品药品监督管理局的药物安全改革——是钟摆摆动还是系统性改进？
N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13.
10
The federal preemption debate in pharmaceutical labeling product liability actions.药品标签产品责任诉讼中的联邦优先适用权辩论。
Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70.
引用本文的文献
1
Maternal gut microbiome interventions to improve maternal and perinatal health outcomes: Target product profile expert consensus and pipeline analysis.改善孕产妇和围产期健康结局的母体肠道微生物群干预措施：目标产品概况专家共识与管线分析
PLoS One. 2025 Jul 2;20(7):e0321543. doi: 10.1371/journal.pone.0321543. eCollection 2025.
2
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program.腺相关病毒基因治疗的发展：推进平台载体基因治疗项目的早期规划与监管考量
Hum Gene Ther. 2025 Mar;36(5-6):653-662. doi: 10.1089/hum.2024.230. Epub 2025 Feb 20.
3
Antiviral target compound profile for pandemic preparedness.大流行防范的抗病毒靶标化合物概况
Nat Rev Drug Discov. 2025 Feb;24(2):151-152. doi: 10.1038/s41573-024-01102-3.
4
Mechanisms of long COVID and the path toward therapeutics.长新冠的发病机制和治疗方法研究进展。
Cell. 2024 Oct 3;187(20):5500-5529. doi: 10.1016/j.cell.2024.07.054. Epub 2024 Sep 25.
5
Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs.在研究内在和外在因素对 PK 和安全性影响的临床药理学研究中评估的剂量：来自已批准药物开发项目的案例示例。
AAPS J. 2024 Jun 17;26(4):71. doi: 10.1208/s12248-024-00935-5.
6
Target product profiles for neonatal care devices: systematic development and outcomes with NEST360 and UNICEF.新生儿护理设备的目标产品概况：NEST360 和儿基会的系统开发和成果。
BMC Pediatr. 2023 Nov 15;23(Suppl 2):564. doi: 10.1186/s12887-023-04342-1.
7
Target product profiles for novel medicines to prevent and treat preeclampsia: An expert consensus.预防和治疗子痫前期新型药物的目标产品概况：专家共识
PLOS Glob Public Health. 2022 Nov 18;2(11):e0001260. doi: 10.1371/journal.pgph.0001260. eCollection 2022.
8
Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.企业通过使用动态目标产品简介将卫生技术评估/支付方观点纳入药物研发的挑战与机遇
Front Pharmacol. 2022 Jul 18;13:948161. doi: 10.3389/fphar.2022.948161. eCollection 2022.
9
Rapid point-of-care testing for COVID-19: quality of supportive information for lateral flow serology assays.用于 COVID-19 的即时检测：侧向流血清学检测的支持性信息质量。
BMJ Open. 2021 Mar 19;11(3):e047163. doi: 10.1136/bmjopen-2020-047163.
10
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile.利用真实世界数据，根据未来药物的目标产品概况预测其临床和经济效益。
Drugs Real World Outcomes. 2020 Sep;7(3):221-227. doi: 10.1007/s40801-020-00203-w.
Zotero 插件